Success Metrics

Clinical Success Rate
100.0%

Based on 9 completed trials

Completion Rate
100%(9/9)
Active Trials
3(20%)
Results Posted
22%(2 trials)

Phase Distribution

Ph phase_1
1
7%
Ph phase_4
8
53%
Ph phase_2
4
27%
Ph phase_3
1
7%

Phase Distribution

1

Early Stage

4

Mid Stage

9

Late Stage

Phase Distribution14 total trials
Phase 1Safety & dosage
1(7.1%)
Phase 2Efficacy & side effects
4(28.6%)
Phase 3Large-scale testing
1(7.1%)
Phase 4Post-market surveillance
8(57.1%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

100.0%

9 of 9 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

3

trials recruiting

Total Trials

15

all time

Status Distribution
Active(4)
Completed(9)
Other(2)

Detailed Status

Completed9
Recruiting3
Not yet recruiting1
Suspended1
unknown1

Development Timeline

Analytics

Development Status

Total Trials
15
Active
3
Success Rate
100.0%
Most Advanced
Phase 4

Trials by Phase

Phase 11 (7.1%)
Phase 24 (28.6%)
Phase 31 (7.1%)
Phase 48 (57.1%)

Trials by Status

not_yet_recruiting17%
suspended17%
unknown17%
completed960%
recruiting320%

Recent Activity

Clinical Trials (15)

Showing 15 of 15 trials
NCT07325240Phase 4

24-hour Effect of Rocklatan Compared With Latanoprost in Open Angle Glaucoma and Ocular Hypertension Patients

Recruiting
NCT07465913Phase 4

Rocklatan vs Latanoprost Post-DSLT

Not Yet Recruiting
NCT04412096Phase 4

Aqueous Humor Dynamic Components That Determine Intraocular Pressure Variance

Completed
NCT06441643Phase 2

Next Generation Rocklatan

Completed
NCT06964191Phase 2

Evaluate Efficacy and Safety of PA5108 Ocular Implants in Primary Open Angle Glaucoma or Ocular Hypertension

Recruiting
NCT06883123Phase 4

Efficacy of Simbrinza and Rocklatan vs Cosopt and Latanoprost

Recruiting
NCT04761705Phase 1

Safety and Efficacy Study of JV-GL1 in Patients With Open-Angle Glaucoma or Ocular Hypertension

Suspended
NCT05513924Phase 2

Comparative Study Between Topical 5-fluorouracil and Latanoprost in Vitiligo.

Completed
NCT05606796Phase 4

Comparison of Preserved and Preservative-free Latanoprost 0.005% in Primary Open Angle Glaucoma and Ocular Hypertensive Patients, at Guinness Eye Centre, Lagos.

Unknown
NCT00856622Phase 3

A Study Demonstrating The Effect Of Latanoprost In Combination With Timolol, Latanoprost Alone And Timolol Alone On Eye Pressure In Open Angle Glaucoma Or Ocular Hypertension In Patients

Completed
NCT00847483Phase 4

Comparison of Latanoprost With Travoprost and Bimatoprost in Patients With Elevated IOP. A 12-weeks, Masked Evaluator, Phase IV Multi-center Study in the US

Completed
NCT04461249

Comparison Between Latanoprost , Travoprost and Tafluprost in Reducing IOP Fluctuation in POAG Patients

Completed
NCT01243567Phase 4

Safety and Efficacy of Bimatoprost/Timolol Fixed Combination Versus Latanoprost in Patients With Open-Angle Glaucoma Who Have Never Been Treated

Completed
NCT01525173Phase 4

A Safety and Efficacy Study of ALPHAGAN® P and LUMIGAN® in Subjects Previously Treated With Latanoprost for Glaucoma and Ocular Hypertension

Completed
NCT00069706Phase 2

Phase II Safety and Efficacy Study to Evaluate a Glaucoma Therapy in Open-angle Glaucoma or Ocular Hypertension Patients

Completed

All 15 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
15